Search results

news-media-release
Repair and Review in Nuclear Medicine Processing and Distribution Facility 20/07/2018

The Australian Nuclear Science and Technology Organisation (ANSTO) is importing technetium-99m (Tc-99m) generators from the United States to supply Australian hospitals, clinics and pharmaceutical suppliers. 

news-media-release
Technetium-99m (Tc-99m) Generator production at ANSTO 27/06/2018

Technetium-99m (Tc-99m) is used in hospitals around the world to diagnose a variety of heart, lung and musculoskeletal conditions, as well as cancers. It is the most common nuclear medicine, with global demand estimated to be up to 40 million doses a year, produced by experts with a small network of 11* nuclear reactors worldwide.

news-media-release
Nuclear medicine production at ANSTO 08/06/2018

Media Statement on nuclear medicine production

news-media-release
Nuclear medicine supplies guaranteed during South Sydney fire crisis 17/04/2018

ANSTO to reopen to staff tomorrow 18th, April. School holiday workshops, external tours cancelled until Monday.

news-media-release
ANSTO continues to take advice about bushfires in region 15/04/2018

ANSTO always works with local emergency services, and the Rural Fire Service has advised no risk to ANSTO as a result of the fires in the vicinity of our Lucas Heights campus.

 

Opal-moving-06-april-thumb
Australia’s OPAL multi-purpose reactor prepares for new milestone 12/04/2018

In mid-2018, ANSTO, together with several State and Federal Government agencies, will undertake Australia’s 10th routine transport of spent nuclear fuel assemblies.

news-media-release
ANSTO recognises local Indigenous heritage in new mural 18/12/2017

ANSTO has recognised the indigenous culture and history that surrounds our campus, with the creation of a Dharawal Mural.

news-media-release
Report to the independent nuclear regulator, ARPANSA, and the IAEA 14/12/2017

Today the independent nuclear regulator, ARPANSA, has released an Inspection Report in relation to ANSTO’s radiopharmaceutical production facilities.

ANM media centre thumbnail
Australia’s new Mo-99 manufacturing facility reaches practical completion 30/11/2017

The ANSTO Nuclear Medicine (ANM) project has achieved a new milestone, reaching practical completion for the Molybdenum-99 (Mo-99) production facility, with contractors handing over the facility to the Australian Nuclear Science and Technology Organisation (ANSTO) to complete the final stages of commissioning.

nstli-awards-thumb
ANSTO's best and brightest recognised in 2017 research awards 27/11/2017

The man behind Australia’s development and advanced manufacturing of nuclear medicine used in hospitals to diagnose cancers and heart disease has been amongst a number of researchers recognised for their achievements at the ANSTO Awards in Nuclear Science and Technology 2017 presentation dinner.

Find more...

Media enquiry form

If you have a media enquiry please call
Phil McCall: +61 438 619 987

Or

Send »

Please provide us with your name, phone number and
email so we can get back to you.

Error: Enquiry was not sent! Check all fields have been populated correctly.
Success: Enquiry was sent successfully.

Publications »